nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—ADRB1—type 1 diabetes mellitus	0.498	1	CbGaD
Carvedilol—Renal artery stenosis—Ramipril—type 1 diabetes mellitus	0.0237	0.145	CcSEcCtD
Carvedilol—VCAM1—tunica intima—type 1 diabetes mellitus	0.0185	0.156	CbGeAlD
Carvedilol—Dermatitis psoriasiform—Ramipril—type 1 diabetes mellitus	0.011	0.0677	CcSEcCtD
Carvedilol—Hypotension symptomatic—Ramipril—type 1 diabetes mellitus	0.00983	0.0604	CcSEcCtD
Carvedilol—HIF1A—nerve—type 1 diabetes mellitus	0.00605	0.051	CbGeAlD
Carvedilol—Depressed mood—Ramipril—type 1 diabetes mellitus	0.00381	0.0234	CcSEcCtD
Carvedilol—Cerebrovascular disorder—Ramipril—type 1 diabetes mellitus	0.00381	0.0234	CcSEcCtD
Carvedilol—NPPB—cardiovascular system—type 1 diabetes mellitus	0.00354	0.0299	CbGeAlD
Carvedilol—Kidney function abnormal—Ramipril—type 1 diabetes mellitus	0.00353	0.0217	CcSEcCtD
Carvedilol—Peripheral vascular disorder—Ramipril—type 1 diabetes mellitus	0.00348	0.0213	CcSEcCtD
Carvedilol—NPPB—pancreas—type 1 diabetes mellitus	0.00344	0.029	CbGeAlD
Carvedilol—VCAM1—islet of Langerhans—type 1 diabetes mellitus	0.00304	0.0257	CbGeAlD
Carvedilol—Sleep disturbance—Ramipril—type 1 diabetes mellitus	0.00304	0.0187	CcSEcCtD
Carvedilol—GJA1—Enalapril—Ramipril—type 1 diabetes mellitus	0.00299	0.532	CbGdCrCtD
Carvedilol—NPPB—lymphoid tissue—type 1 diabetes mellitus	0.00298	0.0251	CbGeAlD
Carvedilol—HIF1A—islet of Langerhans—type 1 diabetes mellitus	0.00293	0.0247	CbGeAlD
Carvedilol—GJA1—islet of Langerhans—type 1 diabetes mellitus	0.00284	0.024	CbGeAlD
Carvedilol—Psoriasis—Ramipril—type 1 diabetes mellitus	0.00271	0.0167	CcSEcCtD
Carvedilol—SELE—nephron tubule—type 1 diabetes mellitus	0.00266	0.0225	CbGeAlD
Carvedilol—VEGFA—Enalapril—Ramipril—type 1 diabetes mellitus	0.00263	0.468	CbGdCrCtD
Carvedilol—VCAM1—retina—type 1 diabetes mellitus	0.0026	0.022	CbGeAlD
Carvedilol—HIF1A—retina—type 1 diabetes mellitus	0.0025	0.0211	CbGeAlD
Carvedilol—Neuralgia—Ramipril—type 1 diabetes mellitus	0.00245	0.0151	CcSEcCtD
Carvedilol—VCAM1—nephron tubule—type 1 diabetes mellitus	0.00245	0.0207	CbGeAlD
Carvedilol—GJA1—retina—type 1 diabetes mellitus	0.00243	0.0205	CbGeAlD
Carvedilol—SELE—cardiovascular system—type 1 diabetes mellitus	0.00239	0.0202	CbGeAlD
Carvedilol—HIF1A—nephron tubule—type 1 diabetes mellitus	0.00236	0.0199	CbGeAlD
Carvedilol—GJA1—nephron tubule—type 1 diabetes mellitus	0.00229	0.0193	CbGeAlD
Carvedilol—VEGFA—islet of Langerhans—type 1 diabetes mellitus	0.00224	0.0189	CbGeAlD
Carvedilol—VCAM1—cardiovascular system—type 1 diabetes mellitus	0.0022	0.0186	CbGeAlD
Carvedilol—VCAM1—kidney—type 1 diabetes mellitus	0.00215	0.0182	CbGeAlD
Carvedilol—VCAM1—pancreas—type 1 diabetes mellitus	0.00214	0.018	CbGeAlD
Carvedilol—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.00212	0.013	CcSEcCtD
Carvedilol—HIF1A—cardiovascular system—type 1 diabetes mellitus	0.00212	0.0179	CbGeAlD
Carvedilol—NDUFC2—retina—type 1 diabetes mellitus	0.00211	0.0178	CbGeAlD
Carvedilol—HIF1A—kidney—type 1 diabetes mellitus	0.00207	0.0175	CbGeAlD
Carvedilol—HIF1A—pancreas—type 1 diabetes mellitus	0.00206	0.0174	CbGeAlD
Carvedilol—GJA1—cardiovascular system—type 1 diabetes mellitus	0.00205	0.0173	CbGeAlD
Carvedilol—Liver injury—Ramipril—type 1 diabetes mellitus	0.00203	0.0124	CcSEcCtD
Carvedilol—SELE—lymphoid tissue—type 1 diabetes mellitus	0.00201	0.017	CbGeAlD
Carvedilol—GJA1—kidney—type 1 diabetes mellitus	0.00201	0.017	CbGeAlD
Carvedilol—GJA1—pancreas—type 1 diabetes mellitus	0.002	0.0168	CbGeAlD
Carvedilol—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00197	0.0121	CcSEcCtD
Carvedilol—Cough increased—Ramipril—type 1 diabetes mellitus	0.00186	0.0114	CcSEcCtD
Carvedilol—VCAM1—lymphoid tissue—type 1 diabetes mellitus	0.00185	0.0156	CbGeAlD
Carvedilol—VEGFA—nephron tubule—type 1 diabetes mellitus	0.00181	0.0152	CbGeAlD
Carvedilol—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00179	0.011	CcSEcCtD
Carvedilol—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00179	0.011	CcSEcCtD
Carvedilol—NDUFC2—cardiovascular system—type 1 diabetes mellitus	0.00179	0.0151	CbGeAlD
Carvedilol—HIF1A—lymphoid tissue—type 1 diabetes mellitus	0.00178	0.015	CbGeAlD
Carvedilol—NDUFC2—kidney—type 1 diabetes mellitus	0.00175	0.0148	CbGeAlD
Carvedilol—GJA1—lymphoid tissue—type 1 diabetes mellitus	0.00173	0.0146	CbGeAlD
Carvedilol—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.0017	0.0143	CbGeAlD
Carvedilol—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.00161	0.00988	CcSEcCtD
Carvedilol—VEGFA—pancreas—type 1 diabetes mellitus	0.00158	0.0133	CbGeAlD
Carvedilol—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.00155	0.00952	CcSEcCtD
Carvedilol—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.00153	0.00937	CcSEcCtD
Carvedilol—Bevantolol—ADRB1—type 1 diabetes mellitus	0.0015	0.36	CrCbGaD
Carvedilol—NDUFC2—lymphoid tissue—type 1 diabetes mellitus	0.0015	0.0127	CbGeAlD
Carvedilol—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00143	0.00878	CcSEcCtD
Carvedilol—XDH—kidney—type 1 diabetes mellitus	0.00141	0.0119	CbGeAlD
Carvedilol—Bopindolol—ADRB1—type 1 diabetes mellitus	0.00139	0.333	CrCbGaD
Carvedilol—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00138	0.0085	CcSEcCtD
Carvedilol—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00136	0.00834	CcSEcCtD
Carvedilol—Renal failure acute—Ramipril—type 1 diabetes mellitus	0.00134	0.00823	CcSEcCtD
Carvedilol—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00133	0.0082	CcSEcCtD
Carvedilol—Amnesia—Ramipril—type 1 diabetes mellitus	0.00132	0.00809	CcSEcCtD
Carvedilol—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.00131	0.00805	CcSEcCtD
Carvedilol—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00131	0.00802	CcSEcCtD
Carvedilol—Renal impairment—Ramipril—type 1 diabetes mellitus	0.0013	0.00799	CcSEcCtD
Carvedilol—Purpura—Ramipril—type 1 diabetes mellitus	0.00128	0.00789	CcSEcCtD
Carvedilol—Anaphylactoid reaction—Ramipril—type 1 diabetes mellitus	0.00128	0.00785	CcSEcCtD
Carvedilol—Arthritis—Ramipril—type 1 diabetes mellitus	0.00127	0.00782	CcSEcCtD
Carvedilol—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.00127	0.00779	CcSEcCtD
Carvedilol—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.00127	0.00779	CcSEcCtD
Carvedilol—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.00126	0.00776	CcSEcCtD
Carvedilol—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.00124	0.00763	CcSEcCtD
Carvedilol—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00123	0.00754	CcSEcCtD
Carvedilol—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.00116	0.00712	CcSEcCtD
Carvedilol—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.00113	0.00694	CcSEcCtD
Carvedilol—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00111	0.00684	CcSEcCtD
Carvedilol—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00111	0.00684	CcSEcCtD
Carvedilol—Influenza—Ramipril—type 1 diabetes mellitus	0.00107	0.00657	CcSEcCtD
Carvedilol—ADRA1B—kidney—type 1 diabetes mellitus	0.00106	0.00894	CbGeAlD
Carvedilol—Bronchospasm—Ramipril—type 1 diabetes mellitus	0.00105	0.00646	CcSEcCtD
Carvedilol—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00104	0.0064	CcSEcCtD
Carvedilol—Sweating increased—Ramipril—type 1 diabetes mellitus	0.00104	0.0064	CcSEcCtD
Carvedilol—Bronchitis—Ramipril—type 1 diabetes mellitus	0.00103	0.00632	CcSEcCtD
Carvedilol—Pancytopenia—Ramipril—type 1 diabetes mellitus	0.00102	0.00624	CcSEcCtD
Carvedilol—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.000994	0.0061	CcSEcCtD
Carvedilol—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.000985	0.00605	CcSEcCtD
Carvedilol—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000976	0.006	CcSEcCtD
Carvedilol—Weight increased—Ramipril—type 1 diabetes mellitus	0.000974	0.00598	CcSEcCtD
Carvedilol—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.000946	0.00581	CcSEcCtD
Carvedilol—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.00094	0.00577	CcSEcCtD
Carvedilol—Renal failure—Ramipril—type 1 diabetes mellitus	0.000938	0.00576	CcSEcCtD
Carvedilol—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.000935	0.00574	CcSEcCtD
Carvedilol—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.000927	0.00569	CcSEcCtD
Carvedilol—Sinusitis—Ramipril—type 1 diabetes mellitus	0.000895	0.00549	CcSEcCtD
Carvedilol—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000843	0.00518	CcSEcCtD
Carvedilol—Visual impairment—Ramipril—type 1 diabetes mellitus	0.000825	0.00507	CcSEcCtD
Carvedilol—KCNH2—islet of Langerhans—type 1 diabetes mellitus	0.000813	0.00686	CbGeAlD
Carvedilol—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00081	0.00497	CcSEcCtD
Carvedilol—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000798	0.0049	CcSEcCtD
Carvedilol—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000773	0.00475	CcSEcCtD
Carvedilol—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000772	0.00474	CcSEcCtD
Carvedilol—ADRB1—cardiovascular system—type 1 diabetes mellitus	0.00077	0.00649	CbGeAlD
Carvedilol—Propafenone—ADRB1—type 1 diabetes mellitus	0.000763	0.182	CrCbGaD
Carvedilol—Alopecia—Ramipril—type 1 diabetes mellitus	0.000757	0.00465	CcSEcCtD
Carvedilol—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000745	0.00458	CcSEcCtD
Carvedilol—Tension—Ramipril—type 1 diabetes mellitus	0.000731	0.00449	CcSEcCtD
Carvedilol—Nervousness—Ramipril—type 1 diabetes mellitus	0.000724	0.00445	CcSEcCtD
Carvedilol—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000717	0.0044	CcSEcCtD
Carvedilol—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000692	0.00425	CcSEcCtD
Carvedilol—Angioedema—Ramipril—type 1 diabetes mellitus	0.000681	0.00418	CcSEcCtD
Carvedilol—Malaise—Ramipril—type 1 diabetes mellitus	0.000672	0.00413	CcSEcCtD
Carvedilol—Vertigo—Ramipril—type 1 diabetes mellitus	0.00067	0.00411	CcSEcCtD
Carvedilol—Syncope—Ramipril—type 1 diabetes mellitus	0.000668	0.0041	CcSEcCtD
Carvedilol—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000667	0.0041	CcSEcCtD
Carvedilol—Palpitations—Ramipril—type 1 diabetes mellitus	0.000659	0.00404	CcSEcCtD
Carvedilol—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000655	0.00402	CcSEcCtD
Carvedilol—Cough—Ramipril—type 1 diabetes mellitus	0.00065	0.00399	CcSEcCtD
Carvedilol—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.000646	0.00545	CbGeAlD
Carvedilol—Convulsion—Ramipril—type 1 diabetes mellitus	0.000646	0.00397	CcSEcCtD
Carvedilol—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.00064	0.0054	CbGeAlD
Carvedilol—Arthralgia—Ramipril—type 1 diabetes mellitus	0.000635	0.0039	CcSEcCtD
Carvedilol—Chest pain—Ramipril—type 1 diabetes mellitus	0.000635	0.0039	CcSEcCtD
Carvedilol—Myalgia—Ramipril—type 1 diabetes mellitus	0.000635	0.0039	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00063	0.00387	CcSEcCtD
Carvedilol—Discomfort—Ramipril—type 1 diabetes mellitus	0.000627	0.00385	CcSEcCtD
Carvedilol—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000621	0.00381	CcSEcCtD
Carvedilol—Confusional state—Ramipril—type 1 diabetes mellitus	0.000613	0.00377	CcSEcCtD
Carvedilol—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000609	0.00514	CbGeAlD
Carvedilol—Oedema—Ramipril—type 1 diabetes mellitus	0.000608	0.00374	CcSEcCtD
Carvedilol—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000608	0.00374	CcSEcCtD
Carvedilol—Shock—Ramipril—type 1 diabetes mellitus	0.000598	0.00367	CcSEcCtD
Carvedilol—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000596	0.00366	CcSEcCtD
Carvedilol—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000594	0.00365	CcSEcCtD
Carvedilol—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000591	0.00363	CcSEcCtD
Carvedilol—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000588	0.00361	CcSEcCtD
Carvedilol—KCNH2—cardiovascular system—type 1 diabetes mellitus	0.000588	0.00496	CbGeAlD
Carvedilol—Anorexia—Ramipril—type 1 diabetes mellitus	0.00058	0.00356	CcSEcCtD
Carvedilol—Hypotension—Ramipril—type 1 diabetes mellitus	0.000568	0.00349	CcSEcCtD
Carvedilol—ADRA2C—kidney—type 1 diabetes mellitus	0.000568	0.00479	CbGeAlD
Carvedilol—ADRA2C—pancreas—type 1 diabetes mellitus	0.000564	0.00476	CbGeAlD
Carvedilol—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000554	0.0034	CcSEcCtD
Carvedilol—Insomnia—Ramipril—type 1 diabetes mellitus	0.00055	0.00338	CcSEcCtD
Carvedilol—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.000546	0.00335	CcSEcCtD
Carvedilol—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000542	0.00333	CcSEcCtD
Carvedilol—Somnolence—Ramipril—type 1 diabetes mellitus	0.000541	0.00332	CcSEcCtD
Carvedilol—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000535	0.00329	CcSEcCtD
Carvedilol—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.000529	0.00325	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000525	0.00322	CcSEcCtD
Carvedilol—Fatigue—Ramipril—type 1 diabetes mellitus	0.000524	0.00322	CcSEcCtD
Carvedilol—Propranolol—ADRB1—type 1 diabetes mellitus	0.000523	0.125	CrCbGaD
Carvedilol—Constipation—Ramipril—type 1 diabetes mellitus	0.00052	0.00319	CcSEcCtD
Carvedilol—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000512	0.00432	CbGeAlD
Carvedilol—CYP2E1—nephron tubule—type 1 diabetes mellitus	0.000504	0.00425	CbGeAlD
Carvedilol—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000501	0.00308	CcSEcCtD
Carvedilol—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000497	0.00305	CcSEcCtD
Carvedilol—CYP1A1—kidney—type 1 diabetes mellitus	0.000486	0.0041	CbGeAlD
Carvedilol—Urticaria—Ramipril—type 1 diabetes mellitus	0.000483	0.00297	CcSEcCtD
Carvedilol—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000481	0.00295	CcSEcCtD
Carvedilol—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000481	0.00295	CcSEcCtD
Carvedilol—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.000478	0.00403	CbGeAlD
Carvedilol—CYP2E1—cardiovascular system—type 1 diabetes mellitus	0.000453	0.00382	CbGeAlD
Carvedilol—ADRA2A—pancreas—type 1 diabetes mellitus	0.00045	0.00379	CbGeAlD
Carvedilol—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000448	0.00275	CcSEcCtD
Carvedilol—CYP2E1—kidney—type 1 diabetes mellitus	0.000443	0.00374	CbGeAlD
Carvedilol—Asthenia—Ramipril—type 1 diabetes mellitus	0.000436	0.00268	CcSEcCtD
Carvedilol—PTGS1—cardiovascular system—type 1 diabetes mellitus	0.000436	0.00368	CbGeAlD
Carvedilol—Pruritus—Ramipril—type 1 diabetes mellitus	0.00043	0.00264	CcSEcCtD
Carvedilol—PTGS1—kidney—type 1 diabetes mellitus	0.000427	0.0036	CbGeAlD
Carvedilol—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000416	0.00256	CcSEcCtD
Carvedilol—Dizziness—Ramipril—type 1 diabetes mellitus	0.000402	0.00247	CcSEcCtD
Carvedilol—Vomiting—Ramipril—type 1 diabetes mellitus	0.000387	0.00237	CcSEcCtD
Carvedilol—Rash—Ramipril—type 1 diabetes mellitus	0.000384	0.00236	CcSEcCtD
Carvedilol—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000383	0.00235	CcSEcCtD
Carvedilol—Headache—Ramipril—type 1 diabetes mellitus	0.000381	0.00234	CcSEcCtD
Carvedilol—CYP2E1—lymphoid tissue—type 1 diabetes mellitus	0.000381	0.00321	CbGeAlD
Carvedilol—Nausea—Ramipril—type 1 diabetes mellitus	0.000361	0.00222	CcSEcCtD
Carvedilol—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000357	0.00301	CbGeAlD
Carvedilol—CYP3A4—kidney—type 1 diabetes mellitus	0.000357	0.00301	CbGeAlD
Carvedilol—CYP2D6—kidney—type 1 diabetes mellitus	0.000351	0.00296	CbGeAlD
Carvedilol—ABCB1—retina—type 1 diabetes mellitus	0.000305	0.00257	CbGeAlD
Carvedilol—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000287	0.00242	CbGeAlD
Carvedilol—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000258	0.00218	CbGeAlD
Carvedilol—ABCB1—kidney—type 1 diabetes mellitus	0.000252	0.00213	CbGeAlD
Carvedilol—ABCB1—pancreas—type 1 diabetes mellitus	0.000251	0.00211	CbGeAlD
Carvedilol—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000217	0.00183	CbGeAlD
Carvedilol—ADRB2—Signaling by GPCR—TYK2—type 1 diabetes mellitus	9.39e-06	4.46e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.37e-06	4.45e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—NOS3—type 1 diabetes mellitus	9.35e-06	4.44e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IGF2—type 1 diabetes mellitus	9.35e-06	4.44e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—GCG—type 1 diabetes mellitus	9.32e-06	4.42e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CD86—type 1 diabetes mellitus	9.2e-06	4.37e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—GCG—type 1 diabetes mellitus	9.14e-06	4.34e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CD86—type 1 diabetes mellitus	9.12e-06	4.33e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.11e-06	4.32e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	9.07e-06	4.31e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	9.04e-06	4.29e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	9.03e-06	4.28e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CD86—type 1 diabetes mellitus	9e-06	4.27e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	8.97e-06	4.26e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	8.96e-06	4.25e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.96e-06	4.25e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.88e-06	4.22e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	8.86e-06	4.2e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.85e-06	4.2e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.83e-06	4.19e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	8.81e-06	4.18e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.79e-06	4.17e-05	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.79e-06	4.17e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—GCG—type 1 diabetes mellitus	8.79e-06	4.17e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL2—type 1 diabetes mellitus	8.76e-06	4.16e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	8.74e-06	4.15e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.73e-06	4.15e-05	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.71e-06	4.14e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IGF2—type 1 diabetes mellitus	8.71e-06	4.13e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.65e-06	4.11e-05	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.6e-06	4.08e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	8.59e-06	4.08e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.54e-06	4.06e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	8.54e-06	4.05e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CD86—type 1 diabetes mellitus	8.52e-06	4.04e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	8.52e-06	4.04e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	8.51e-06	4.04e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	8.49e-06	4.03e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	8.45e-06	4.01e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	8.43e-06	4e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CD86—type 1 diabetes mellitus	8.38e-06	3.98e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	8.38e-06	3.98e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	8.3e-06	3.94e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.3e-06	3.94e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	8.23e-06	3.91e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.22e-06	3.9e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	8.17e-06	3.88e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.16e-06	3.87e-05	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.14e-06	3.86e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	8.12e-06	3.85e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCR5—type 1 diabetes mellitus	8.09e-06	3.84e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	8.08e-06	3.84e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL2RA—type 1 diabetes mellitus	8.05e-06	3.82e-05	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	8.01e-06	3.8e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.99e-06	3.79e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.98e-06	3.79e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.97e-06	3.78e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.96e-06	3.78e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.96e-06	3.78e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL2—type 1 diabetes mellitus	7.95e-06	3.77e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CASP3—type 1 diabetes mellitus	7.94e-06	3.77e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	7.94e-06	3.77e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL2—type 1 diabetes mellitus	7.93e-06	3.76e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	7.91e-06	3.76e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.91e-06	3.76e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—IL6—type 1 diabetes mellitus	7.91e-06	3.75e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CAT—type 1 diabetes mellitus	7.89e-06	3.75e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.87e-06	3.74e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.81e-06	3.71e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.76e-06	3.69e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.73e-06	3.67e-05	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	7.72e-06	3.66e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.68e-06	3.65e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ITPR3—type 1 diabetes mellitus	7.66e-06	3.63e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	7.59e-06	3.6e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	7.56e-06	3.59e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.56e-06	3.59e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	7.45e-06	3.54e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.45e-06	3.53e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CAT—type 1 diabetes mellitus	7.44e-06	3.53e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCR5—type 1 diabetes mellitus	7.44e-06	3.53e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.39e-06	3.51e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CD80—type 1 diabetes mellitus	7.37e-06	3.5e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	7.33e-06	3.48e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL2—type 1 diabetes mellitus	7.27e-06	3.45e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	7.21e-06	3.42e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—HBA1—type 1 diabetes mellitus	7.21e-06	3.42e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	7.19e-06	3.41e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOC3—type 1 diabetes mellitus	7.16e-06	3.4e-05	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	7.11e-06	3.38e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	7.07e-06	3.35e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTT1—type 1 diabetes mellitus	7.03e-06	3.34e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—INS—type 1 diabetes mellitus	7.02e-06	3.33e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	7.02e-06	3.33e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—INS—type 1 diabetes mellitus	7.01e-06	3.33e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	7e-06	3.32e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—INS—type 1 diabetes mellitus	6.96e-06	3.31e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	6.92e-06	3.28e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.74e-06	3.2e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.72e-06	3.19e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CD80—type 1 diabetes mellitus	6.71e-06	3.19e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.7e-06	3.18e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.69e-06	3.17e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—STAT3—type 1 diabetes mellitus	6.67e-06	3.17e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	6.65e-06	3.16e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	6.62e-06	3.14e-05	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	6.61e-06	3.14e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.61e-06	3.14e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CD80—type 1 diabetes mellitus	6.57e-06	3.12e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	6.57e-06	3.12e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	6.56e-06	3.11e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.51e-06	3.09e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.48e-06	3.08e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	6.46e-06	3.07e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	6.44e-06	3.06e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—ALB—type 1 diabetes mellitus	6.43e-06	3.05e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—INS—type 1 diabetes mellitus	6.34e-06	3.01e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	6.29e-06	2.98e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	6.24e-06	2.96e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.22e-06	2.95e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	6.21e-06	2.95e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—INS—type 1 diabetes mellitus	6.21e-06	2.95e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	6.16e-06	2.92e-05	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—NOS3—type 1 diabetes mellitus	6.15e-06	2.92e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	6.14e-06	2.91e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.14e-06	2.91e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CD80—type 1 diabetes mellitus	6.12e-06	2.9e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.11e-06	2.9e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.11e-06	2.9e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	6.08e-06	2.89e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.08e-06	2.88e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—EGFR—type 1 diabetes mellitus	6.06e-06	2.88e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	6.05e-06	2.87e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	6.05e-06	2.87e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IGF1—type 1 diabetes mellitus	6e-06	2.85e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	6e-06	2.85e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.97e-06	2.84e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	5.94e-06	2.82e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	5.91e-06	2.8e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	5.87e-06	2.79e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	5.78e-06	2.74e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	5.7e-06	2.71e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.68e-06	2.7e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.67e-06	2.69e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.65e-06	2.68e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.62e-06	2.67e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GCG—type 1 diabetes mellitus	5.6e-06	2.66e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	5.6e-06	2.66e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.59e-06	2.65e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.56e-06	2.64e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.56e-06	2.64e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	5.56e-06	2.64e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	5.55e-06	2.64e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.54e-06	2.63e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	5.53e-06	2.62e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.51e-06	2.62e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.44e-06	2.58e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.43e-06	2.58e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	5.43e-06	2.58e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.25e-06	2.49e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—INS—type 1 diabetes mellitus	5.24e-06	2.49e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	5.23e-06	2.48e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.18e-06	2.46e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL2—type 1 diabetes mellitus	5.18e-06	2.46e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.16e-06	2.45e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.15e-06	2.44e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.15e-06	2.44e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	5.13e-06	2.44e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.07e-06	2.41e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.05e-06	2.4e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	5e-06	2.37e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.97e-06	2.36e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.94e-06	2.35e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—INS—type 1 diabetes mellitus	4.94e-06	2.34e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ALB—type 1 diabetes mellitus	4.8e-06	2.28e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	4.77e-06	2.26e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CAT—type 1 diabetes mellitus	4.74e-06	2.25e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.72e-06	2.24e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.72e-06	2.24e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.69e-06	2.23e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.68e-06	2.22e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	4.67e-06	2.22e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—type 1 diabetes mellitus	4.67e-06	2.22e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—type 1 diabetes mellitus	4.66e-06	2.21e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.65e-06	2.21e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.62e-06	2.19e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL2—type 1 diabetes mellitus	4.61e-06	2.19e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.61e-06	2.19e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NOS3—type 1 diabetes mellitus	4.59e-06	2.18e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.59e-06	2.18e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.59e-06	2.18e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.59e-06	2.18e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ALB—type 1 diabetes mellitus	4.53e-06	2.15e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.5e-06	2.14e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.37e-06	2.08e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	4.37e-06	2.07e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.36e-06	2.07e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.34e-06	2.06e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NOS3—type 1 diabetes mellitus	4.33e-06	2.06e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	4.32e-06	2.05e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.3e-06	2.04e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	4.3e-06	2.04e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.27e-06	2.03e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.26e-06	2.02e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.18e-06	1.99e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.97e-06	1.88e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.96e-06	1.88e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.94e-06	1.87e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.93e-06	1.87e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.88e-06	1.84e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.82e-06	1.81e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.82e-06	1.81e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.8e-06	1.8e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.72e-06	1.76e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	3.68e-06	1.75e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.67e-06	1.74e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	3.66e-06	1.74e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	3.62e-06	1.72e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.62e-06	1.72e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.61e-06	1.71e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.57e-06	1.7e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.55e-06	1.69e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.55e-06	1.68e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.53e-06	1.67e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.53e-06	1.67e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	3.46e-06	1.64e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	3.41e-06	1.62e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	3.38e-06	1.6e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.34e-06	1.58e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.29e-06	1.56e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	3.26e-06	1.55e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	3.23e-06	1.53e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.21e-06	1.52e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—INS—type 1 diabetes mellitus	3.15e-06	1.49e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—type 1 diabetes mellitus	3.04e-06	1.44e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.98e-06	1.42e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.92e-06	1.39e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ALB—type 1 diabetes mellitus	2.89e-06	1.37e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.77e-06	1.32e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NOS3—type 1 diabetes mellitus	2.76e-06	1.31e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.75e-06	1.3e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.71e-06	1.29e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.71e-06	1.29e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.57e-06	1.22e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.53e-06	1.2e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.43e-06	1.15e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.24e-06	1.06e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.23e-06	1.06e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	2.13e-06	1.01e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.08e-06	9.89e-06	CbGpPWpGaD
